Effects of Pathogen-Vector Interactions on the Transmission of Dengue Virus: Difference between revisions

From MicrobeWiki, the student-edited microbiology resource
No edit summary
No edit summary
Line 5: Line 5:
==Dengue Virus==
==Dengue Virus==
<br>
<br>
[[File:Micrograph of dengue virus.jpg‎|240px|thumb|left|Figure 1. Electron micrograph of dengue virus (DENV).[1]]]
[[File:Micrograph of dengue virus.jpg‎|240px|thumb|right|Figure 1. Electron micrograph of dengue virus (DENV).[1]]]
<br><br>
<br><br>
<br> Group IV: ss(+)RNA virus
<br> Group IV: ss(+)RNA virus
Line 13: Line 13:
[[File:Aedes aegypti.jpg‎|400px|thumb|right|Figure 2. Main vector of dengue virus, <I>Aedes aegypti</I> or the Asian tiger mosquito.[2]]]
[[File:Aedes aegypti.jpg‎|400px|thumb|right|Figure 2. Main vector of dengue virus, <I>Aedes aegypti</I> or the Asian tiger mosquito.[2]]]
<br>
<br>
Dengue virus is the causative agent of both classical dengue fever and the more severe dengue hemorrhage fever (DHF) and dengue shock syndrome (DSS)[3]. It is most commonly transmitted by the mosquito vector <I>Aedes aegypti</I>but can replicate within and be transmitted by other members of the genus <I>Aedes</I> including <I>Aedes albopictus</I> (Figure 2)[4]. There are four different serotypes of dengue virus (DENV 1-4). Infection with one serotype affords life-long immunity to that serotype but only partial (heterologous) immunity to other serotypes for a short period of time post-infection. After this initial, partial immunity the risk of developing dengue hemorrhage fever and dengue shock syndrome upon reinfection by another dengue serotype increases.
Dengue virus (DENV) is the causative agent of both classical dengue fever, and the more severe manifestations; dengue hemorrhage fever (DHF) and dengue shock syndrome (DSS)[3]. It is most commonly transmitted by the mosquito vector <I>Aedes aegypti</I> but can be transmitted by other members of the genus <I>Aedes</I> including <I>Aedes albopictus</I> (Figure 2)[4]. There are four different serotypes of dengue virus (DENV 1-4). Infection with one serotype affords life-long immunity to that serotype but only partial (heterologous) immunity to other serotypes for a short period of time post-infection. After initial protective immunity the risk of developing DHF or DSS upon reinfection strain from a different serotype increases.
<br><br>
<br><br>
This increased risk for  severe dengue is a result of antibody-dependent enhancement of viral infection. Dengue virions bind to host heterotypic non-neutralizing antibodies from previous dengue infection. After recent dengue infection there are enough antibodies to neutralize the virus but over time the number of neutralizing antibodies drop to a level where antibodies bind some but not all viral surface entry proteins. This anti-body-virion complex binds to FcγR receptors found on the surface of a variety of immune cells as seen in figure ??.
This increased risk for  severe dengue is the result of antibody-dependent enhancement of viral infection. Host heterotypic non-neutralizing antibodies from previous DENV infection bind DENV virions. After recent DENV infection there are enough antibodies to neutralize any new dengue viruses but overtime the number of neutralizing antibodies drops. At some point there are so few enough antibodies left that upon reinfection with a new strain the anitbodies can bind but not nuetralize the virus. The constant region of the antibody can go on to bind a FcγR receptor on the surface of a number of different types of immune cells.
 
 
<br>
<br>
[[File:AD enhancement figure.jpg‎|400px|thumb|center|Figure ?. Antibody-dependent enhancement of DENV infection. [2]]]
[[File:AD enhancement figure.jpg‎|400px|thumb|center|Figure 3. Antibody-dependent enhancement of DENV infection. [2]]]
<br>
<br>
Normally when a pathogen-antibody complex binds to an FcγR receptor it initiates a cytoxic or phagocytoic response depending on the the immune cell type. Somehow the virus avoids this response and is brought close enough to its host cell receptor which it can bind and infect the cell. The FcγR receptors increase infectivity of the virus in immune cells by increasing overall viral load within the patient which in turn increases the risk of severe complications from dengue infection such as DHF and DSS much more likely.
Normally when a pathogen-antibody complex binds to a FcγR receptor a cytoxic or phagocytoic response initiated by the immunne cell. DENV somehow avoids this response and is brought close enough to its host cell receptor it can bind and infect the cell as seen in figure 3. The FcγR receptors are effect in controlling other pathogens but DENV has evolved to exploit this pathway. The FcγR receptor is not needed for DENV entry but does increase infectivity DENV and allows the virus display cell tropisms not seen in primary DENV infection. With more cells infected more viroins are produced leading to higher levels of viremia in the blood which is correlated with increased risk for DHF and DSS.
increase infectivity of the virus in immune cells by increasing overall viral load within the patient which in turn increases the risk of  
<br><br>
<br><br>
Within serotypes dengue viruses are organized by genotypes, then subtypes, then clades, variants, groups and finally strains [3]. The large number of dengue strains in the world combined with only partial crossover immunity to other strains makes concurrent (multiple strain)  infections or reoccurring dengue infections possible (just like repeated bouts of the flu), especially in areas that have a high prevalence of dengue virus.
Within serotypes dengue viruses are organized by genotypes, then subtypes, then clades, variants, groups and finally strains [3]. The large number of dengue strains in the world combined with only partial crossover immunity to other strains makes concurrent (multiple strain)  infections or reoccurring dengue infections possible (just like repeated bouts of the flu), especially in areas that have a high prevalence of dengue virus.

Revision as of 06:22, 7 December 2010

Effects of Pathogen-Vector Interactions on the Transmission of Dengue Virus

This is a curated page. Report corrections to Microbewiki.

A Viral Biorealm page on the family Effects of Pathogen-Vector Interactions on the Transmission of Dengue Virus

Dengue Virus


Figure 1. Electron micrograph of dengue virus (DENV).[1]




Group IV: ss(+)RNA virus
Family: Flaviviridae
Genus: Flavivirus

Figure 2. Main vector of dengue virus, Aedes aegypti or the Asian tiger mosquito.[2]


Dengue virus (DENV) is the causative agent of both classical dengue fever, and the more severe manifestations; dengue hemorrhage fever (DHF) and dengue shock syndrome (DSS)[3]. It is most commonly transmitted by the mosquito vector Aedes aegypti but can be transmitted by other members of the genus Aedes including Aedes albopictus (Figure 2)[4]. There are four different serotypes of dengue virus (DENV 1-4). Infection with one serotype affords life-long immunity to that serotype but only partial (heterologous) immunity to other serotypes for a short period of time post-infection. After initial protective immunity the risk of developing DHF or DSS upon reinfection strain from a different serotype increases.

This increased risk for severe dengue is the result of antibody-dependent enhancement of viral infection. Host heterotypic non-neutralizing antibodies from previous DENV infection bind DENV virions. After recent DENV infection there are enough antibodies to neutralize any new dengue viruses but overtime the number of neutralizing antibodies drops. At some point there are so few enough antibodies left that upon reinfection with a new strain the anitbodies can bind but not nuetralize the virus. The constant region of the antibody can go on to bind a FcγR receptor on the surface of a number of different types of immune cells.



Figure 3. Antibody-dependent enhancement of DENV infection. [2]


Normally when a pathogen-antibody complex binds to a FcγR receptor a cytoxic or phagocytoic response initiated by the immunne cell. DENV somehow avoids this response and is brought close enough to its host cell receptor it can bind and infect the cell as seen in figure 3. The FcγR receptors are effect in controlling other pathogens but DENV has evolved to exploit this pathway. The FcγR receptor is not needed for DENV entry but does increase infectivity DENV and allows the virus display cell tropisms not seen in primary DENV infection. With more cells infected more viroins are produced leading to higher levels of viremia in the blood which is correlated with increased risk for DHF and DSS. increase infectivity of the virus in immune cells by increasing overall viral load within the patient which in turn increases the risk of

Within serotypes dengue viruses are organized by genotypes, then subtypes, then clades, variants, groups and finally strains [3]. The large number of dengue strains in the world combined with only partial crossover immunity to other strains makes concurrent (multiple strain) infections or reoccurring dengue infections possible (just like repeated bouts of the flu), especially in areas that have a high prevalence of dengue virus.

Dengue viruses are now endemic to tropical areas of the world putting about a third of the world’s population at risk of infection. There are estimated to be over one hundred million new infections per year and rising [4,5]. The rising rates of infection are the result of reduced vector control in areas that need it most and increased vector range. Global warming has made winters much milder at higher latitudes allowing adult and larvae mosquitoes to survive longer into the fall and return earlier in the spring. Dengue virus is becoming a threat to industrialized nations once thought to be too far away from the tropics for Dengue fever to be a threat. In the U.S. the number of indigenous dengue cases is rising. In Brownsville Texas, 25% of the residents who had never travelled outside the united states had antibodies indication prior exposure to the virus [discover article] [6].

The severity of dengue infection also continues to increase. The ratio of dengue hemorrhage fever and dengue shock syndrome cases to classical dengue fever have increased dramatically over the past sixty years. It has become the leading cause of hospitalization and death in children in several endemic countries [6].